Ginkgo Bioworks Holdings Stock In The News

DNA Stock  USD 7.18  0.59  8.95%   
Our overall analysis of Ginkgo Bioworks' news coverage and content from conventional and social sources shows investors' bearish mood towards Ginkgo Bioworks Holdings. The specific impact of Ginkgo Bioworks news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Ginkgo Bioworks' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Ginkgo Bioworks headlines in addition to utilizing other, more conventional financial analysis modules. Check out Ginkgo Bioworks Backtesting and Ginkgo Bioworks Hype Analysis.

Ginkgo Bioworks Today Top News and Investor Outlook

reuters
Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln
https://www.reuters.com/business/healthcare-pharmaceuticals/merck-buys-cancer-therapy-developer-modifi-biosciences-up-13-bln-2024-10-23/
 Bearish
reuters
DNA testing company Nebula accused of violating privacy in US lawsuit
https://www.reuters.com/legal/litigation/dna-testing-company-nebula-accused-violating-privacy-us-lawsuit-2024-10-11/
 Bearish
reuters
Spanish scientists to shed light on mystery of Columbus origins, burial
https://www.reuters.com/science/spanish-scientists-shed-light-mystery-columbus-origins-burial-2024-10-10/
 Neutral
Yahoo News
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture
https://finance.yahoo.com/news/novus-leverages-ginkgo-bioworks-develop-110100790.html
 Bullish
Yahoo News
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology
https://finance.yahoo.com/news/ginkgo-bioworks-launches-ginkgo-datapoints-110100952.html
 Bullish
Yahoo News
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development
https://finance.yahoo.com/news/google-cloud-expands-partnership-ginkgo-174841396.html
 Bullish
Yahoo News
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology
https://finance.yahoo.com/news/ginkgo-bioworks-launches-protein-llm-120100733.html
 Bullish
Yahoo News
Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement
https://finance.yahoo.com/news/ginkgo-regains-compliance-nyse-minimum-203000438.html
 Neutral
Yahoo News
This 1 AI Stock Could Revolutionize Biotech and Pharma
https://finance.yahoo.com/news/1-ai-stock-could-revolutionize-091100011.html
 Bullish
Yahoo News
Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
https://finance.yahoo.com/news/ginkgo-bioworks-announces-participation-morgan-110000629.html
 Neutral

Ginkgo Bioworks Holdings Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Ginkgo and other traded companies coverage with news coverage. We help investors stay connected with Ginkgo headlines for the 25th of November to make an informed investment decision based on correlating the impacts of news items on Ginkgo Stock performance. Please note that trading solely based on the Ginkgo Bioworks Holdings hype is not for everyone as timely availability and quick action are needed to avoid losses.
Ginkgo Bioworks' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Ginkgo Bioworks Holdings investors visualize upcoming and past events in order to time the market based on Ginkgo Bioworks Holdings noise-free hype analysis.
Ginkgo Bioworks stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Ginkgo earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Ginkgo Bioworks that are available to investors today. That information is available publicly through Ginkgo media outlets and privately through word of mouth or via Ginkgo internal channels. However, regardless of the origin, that massive amount of Ginkgo data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ginkgo Bioworks news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ginkgo Bioworks relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ginkgo Bioworks' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ginkgo Bioworks alpha.

Ginkgo Largest EPS Surprises

Earnings surprises can significantly impact Ginkgo Bioworks' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-02-29
2023-12-31-0.1-0.11-0.0110 
2023-08-09
2023-06-30-0.08-0.09-0.0112 
2023-05-10
2023-03-31-0.09-0.11-0.0222 
2021-11-15
2021-09-30-0.04-0.06-0.0250 
2023-11-08
2023-09-30-0.09-0.16-0.0777 
2022-11-14
2022-09-30-0.3-0.41-0.1136 
View All Earnings Estimates

Ginkgo Bioworks Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Ginkgo Bioworks Holdings Stock. Current markets are strongly bullish. About 89% of major world exchanges and indexes are currently up. See today's market update for more information.
news
22nd of November 2024
Man Cleared In Teens Cold-Case Death After Passing Lie Detector Is Now Named A Suspect
at huffpost.com 
prnewswire News
21st of November 2024
Renew Biotechnologies Wins BioTech Breakthrough Award for DNA Sequencing Innovation of the...
at prnewswire.com 
businesswire News
19th of November 2024
DNA Sequencing Research Report 2024 - Global Forecast to 2031 21.3 Billion Market to Benef...
at businesswire.com 
news
14th of November 2024
Smoking pot can increase cancer risk, speed up aging and harm your future children
at nypost.com 
Gurufocus Stories at Macroaxis
13th of November 2024
Ginkgo Bioworks Holdings Inc Q3 2024 Earnings Call Highlights Strategic Restructuring ...
at gurufocus.com 
prnewswire News
12th of November 2024
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
at prnewswire.com 
businesswire News
11th of November 2024
Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advan...
at businesswire.com 
news
8th of November 2024
Vietnam man worries that too pretty daughter not his, shocked by birth switch
at scmp.com 
prnewswire News
4th of November 2024
Disposition of 1322 shares by Mark Dmytruk of Ginkgo Bioworks at 7.576 subject to Rule 16b...
at prnewswire.com 
prnewswire News
23rd of October 2024
Unlock Your Genetic Potential with NutriGuide DNA Testing at Nutrishop
at prnewswire.com 
Gurufocus Stories at Macroaxis
9th of October 2024
Q2 2024 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
at gurufocus.com 

Ginkgo Bioworks Investors Sentiment

The influence of Ginkgo Bioworks' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ginkgo. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ginkgo Bioworks' public news can be used to forecast risks associated with an investment in Ginkgo. The trend in average sentiment can be used to explain how an investor holding Ginkgo can time the market purely based on public headlines and social activities around Ginkgo Bioworks Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ginkgo Bioworks' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ginkgo Bioworks' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ginkgo Bioworks' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ginkgo Bioworks.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ginkgo Bioworks in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ginkgo Bioworks' short interest history, or implied volatility extrapolated from Ginkgo Bioworks options trading.
When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:
Check out Ginkgo Bioworks Backtesting and Ginkgo Bioworks Hype Analysis.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(12.89)
Revenue Per Share
4.291
Quarterly Revenue Growth
0.606
Return On Assets
(0.21)
Return On Equity
(0.64)
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.